Ravi Kode to Graft Survival
This is a "connection" page, showing publications Ravi Kode has written about Graft Survival.
Connection Strength
0.160
-
Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant. 2003 Aug; 17(4):369-76.
Score: 0.054
-
Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival. Transplant Proc. 2001 Nov-Dec; 33(7-8):3195-6.
Score: 0.048
-
Nine year experience with kidney transplantation in patients with positive hepatitis C virus antibody. Transplant Proc. 2001 Feb-Mar; 33(1-2):1186-7.
Score: 0.046
-
Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study. Transplant Proc. 2001 Nov-Dec; 33(7-8):3762-3.
Score: 0.012